202 related articles for article (PubMed ID: 36446381)
41. Differential effects of SARS-CoV-2 variants on central nervous system cells and blood-brain barrier functions.
Proust A; Queval CJ; Harvey R; Adams L; Bennett M; Wilkinson RJ
J Neuroinflammation; 2023 Aug; 20(1):184. PubMed ID: 37537664
[TBL] [Abstract][Full Text] [Related]
42. Pathophysiology of SARS-CoV-2 Infection of Nasal Respiratory and Olfactory Epithelia and Its Clinical Impact.
Chee J; Chern B; Loh WS; Mullol J; Wang Y
Curr Allergy Asthma Rep; 2023 Feb; 23(2):121-131. PubMed ID: 36598732
[TBL] [Abstract][Full Text] [Related]
43. Viral infection and smell loss: The case of COVID-19.
Glezer I; Bruni-Cardoso A; Schechtman D; Malnic B
J Neurochem; 2021 May; 157(4):930-943. PubMed ID: 32970861
[TBL] [Abstract][Full Text] [Related]
44. Subjective and psychophysical olfactory and gustatory dysfunction among COVID-19 outpatients; short- and long-term results.
Jensen MM; Larsen KD; Homøe AS; Simonsen AL; Arndal E; Koch A; Samuelsen GB; Nielsen XC; Todsen T; Homøe P
PLoS One; 2022; 17(10):e0275518. PubMed ID: 36191024
[TBL] [Abstract][Full Text] [Related]
45. Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice.
Kumari P; Rothan HA; Natekar JP; Stone S; Pathak H; Strate PG; Arora K; Brinton MA; Kumar M
Viruses; 2021 Jan; 13(1):. PubMed ID: 33477869
[TBL] [Abstract][Full Text] [Related]
46. Development of a novel peptide to prevent entry of SARS-CoV-2 into lung and olfactory bulb cells of hACE2 expressing mice.
Su P; Zhai D; Wong AHC; Liu F
Mol Brain; 2022 Aug; 15(1):71. PubMed ID: 35945596
[TBL] [Abstract][Full Text] [Related]
47. Why Does the Omicron Variant Largely Spare Olfactory Function? Implications for the Pathogenesis of Anosmia in Coronavirus Disease 2019.
Butowt R; Bilińska K; von Bartheld C
J Infect Dis; 2022 Oct; 226(8):1304-1308. PubMed ID: 35467743
[TBL] [Abstract][Full Text] [Related]
48. Unraveling the Possible Routes of SARS-COV-2 Invasion into the Central Nervous System.
Lima M; Siokas V; Aloizou AM; Liampas I; Mentis AA; Tsouris Z; Papadimitriou A; Mitsias PD; Tsatsakis A; Bogdanos DP; Baloyannis SJ; Dardiotis E
Curr Treat Options Neurol; 2020; 22(11):37. PubMed ID: 32994698
[TBL] [Abstract][Full Text] [Related]
49. SARS-CoV-2-Related Olfactory Dysfunction: Autopsy Findings, Histopathology, and Evaluation of Viral RNA and ACE2 Expression in Olfactory Bulbs.
Dell'Aquila M; Cafiero C; Micera A; Stigliano E; Ottaiano MP; Benincasa G; Schiavone B; Guidobaldi L; Santacroce L; Pisconti S; Arena V; Palmirotta R
Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672185
[TBL] [Abstract][Full Text] [Related]
50. A primer on viral-associated olfactory loss in the era of COVID-19.
Soler ZM; Patel ZM; Turner JH; Holbrook EH
Int Forum Allergy Rhinol; 2020 Jul; 10(7):814-820. PubMed ID: 32271490
[TBL] [Abstract][Full Text] [Related]
51. Olfactory Cleft Measurements and COVID-19-Related Anosmia.
Altundag A; Yıldırım D; Tekcan Sanli DE; Cayonu M; Kandemirli SG; Sanli AN; Arici Duz O; Saatci O
Otolaryngol Head Neck Surg; 2021 Jun; 164(6):1337-1344. PubMed ID: 33045908
[TBL] [Abstract][Full Text] [Related]
52. Magnetic resonance imaging of COVID-19 anosmic patients reveals abnormalities of the olfactory bulb: Preliminary prospective study.
Chetrit A; Lechien JR; Ammar A; Chekkoury-Idrissi Y; Distinguin L; Circiu M; Saussez S; Ballester MC; Vasse M; Berradja N; Hans S; Carlier R; Edjlali M
J Infect; 2020 Nov; 81(5):816-846. PubMed ID: 32739489
[TBL] [Abstract][Full Text] [Related]
53. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.
Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R
EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385
[TBL] [Abstract][Full Text] [Related]
54. SARS-CoV-2 Omicron BA.1 Challenge after Ancestral or Delta Infection in Mice.
Baz M; Deshpande N; Mackenzie-Kludas C; Mordant F; Anderson D; Subbarao K
Emerg Infect Dis; 2022 Nov; 28(11):2352-2355. PubMed ID: 36191630
[TBL] [Abstract][Full Text] [Related]
55. Olfactory loss and brain connectivity after COVID-19.
Esposito F; Cirillo M; De Micco R; Caiazzo G; Siciliano M; Russo AG; Monari C; Coppola N; Tedeschi G; Tessitore A
Hum Brain Mapp; 2022 Apr; 43(5):1548-1560. PubMed ID: 35083823
[TBL] [Abstract][Full Text] [Related]
56. Early postmortem brain MRI findings in COVID-19 non-survivors.
Coolen T; Lolli V; Sadeghi N; Rovai A; Trotta N; Taccone FS; Creteur J; Henrard S; Goffard JC; Dewitte O; Naeije G; Goldman S; De Tiège X
Neurology; 2020 Oct; 95(14):e2016-e2027. PubMed ID: 32546654
[TBL] [Abstract][Full Text] [Related]
57. Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models.
Bauer L; Lendemeijer B; Leijten L; Embregts CWE; Rockx B; Kushner SA; de Vrij FMS; van Riel D
mSphere; 2021 Jun; 6(3):e0027021. PubMed ID: 34160239
[TBL] [Abstract][Full Text] [Related]
58. Covert Pathways to the Cranial Cavity: Could These Be Potential Routes of SARS-CoV-2 to the Brain?
Baig AM
ACS Chem Neurosci; 2020 Oct; 11(20):3185-3187. PubMed ID: 33030333
[TBL] [Abstract][Full Text] [Related]
59. Generation of neutralizing antibodies against Omicron, Gamma and Delta SARS-CoV-2 variants following CoronaVac vaccination.
Silva ARD; Villas-Boas LS; Tozetto-Mendoza TR; Honorato L; Paula A; Witkin SS; Mendes-Correa MC
Rev Inst Med Trop Sao Paulo; 2022; 64():e19. PubMed ID: 35239863
[TBL] [Abstract][Full Text] [Related]
60. Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health.
Doty RL
Trends Mol Med; 2022 Sep; 28(9):781-794. PubMed ID: 35810128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
